Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CPT' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 650 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Cabrero, A; Alegret, M; Sanchez, R; Adzet, T; Laguna, JC; Vazquez, M
      Uncoupling protein-3 mRNA up-regulation in C2C12 myotubes after etomoxir treatment

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
    2. Palumbo, M; Sissi, C; Gatto, B; Moro, S; Zagotto, G
      Quantitation of camptothecin and related compounds

      JOURNAL OF CHROMATOGRAPHY B
    3. Zufia, L; Aldaz, A; Giraldez, J
      Separation methods for camptothecin and related compounds

      JOURNAL OF CHROMATOGRAPHY B
    4. Jung, LL; Zamboni, WC
      Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?

      DRUG RESISTANCE UPDATES
    5. Prip-Buus, C; Thuillier, L; Abadi, N; Prasad, C; Dilling, L; Klasing, J; Demaugre, F; Greenberg, CR; Haworth, JC; Droin, V; Kadhom, N; Gobin, S; Kamoun, P; Girard, J; Bonnefont, JP
      Molecular and enzymatic characterization of a unique carnitine palmitoyltransferase 1A mutation in the Hutterite community

      MOLECULAR GENETICS AND METABOLISM
    6. Koekemoer, TC; Oelofsen, W
      Biochemical properties of porcine white adipose tissue mitochondria and relevance to fatty acid oxidation

      COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY
    7. Kehrer, DFS; Sparreboom, A; Verweij, J; de Bruijn, P; Nierop, CA; van de Schraaf, J; Ruijgrok, EJ; de Jonge, MJA
      Modulation of irinotecan-induced diarrhea by cotreatment with neomycin in cancer patients

      CLINICAL CANCER RESEARCH
    8. Minami, H; Fujii, H; Igarashi, T; Itoh, K; Tamanoi, K; Oguma, T; Sasaki, Y
      Phase I and pharmacological study of a new camptothecin derivative, exatecan mesylate (DX-8951f), infused over 30 minutes every three weeks

      CLINICAL CANCER RESEARCH
    9. Blaney, S; Berg, SL; Pratt, C; Weitman, S; Sullivan, J; Luchtman-Jones, L; Bernstein, M
      A phase I study of irinotecan in pediatric patients: A Pediatric Oncology Group Study

      CLINICAL CANCER RESEARCH
    10. Jagasia, MH; Langer, CJ; Johnson, DH; Yunus, F; Rodgers, JS; Schlabach, LL; Cohen, AG; Shyr, Y; Carbone, DP; DeVore, RF
      Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: A multicenter phase II study

      CLINICAL CANCER RESEARCH
    11. Acin, A; Latorre, JI; Pascual, P
      Three-party entanglement from positronium - art. no. 042107

      PHYSICAL REVIEW A
    12. Gheorghiu-Svirschevski, S
      Nonlinear quantum evolution with maximal entropy production - art. no. 022105

      PHYSICAL REVIEW A
    13. Senter, PD; Beam, KS; Mixan, B; Wahl, AF
      Identification and activities of human carboxylesterases for the activation of CPT-11, a clinically approved anticancer drug

      BIOCONJUGATE CHEMISTRY
    14. Takagi, T; Saotome, T
      Chemotherapy with irinotecan (CPT-11), a topoisomerase-I inhibitor, for refractory and relapsed non-Hodgkin's lymphoma

      LEUKEMIA & LYMPHOMA
    15. Platzer, P; Thalhammer, T; Reznicek, G; Hamilton, G; Zhang, RW; Jager, W
      Metabolism and biliary excretion of the novel anticancer agent 10-hydroxycamptothecin in the isolated perfused rat liver

      INTERNATIONAL JOURNAL OF ONCOLOGY
    16. Agrawal, S; Kandimalla, ER; Yu, D; Hollister, BA; Chen, SF; Dexter, DL; Alford, TL; Hill, B; Bailey, KS; Bono, CP; Knoerzer, DL; Morton, PA
      Potentiation of antitumor activity of irinotecan by chemically modified oligonucleotides

      INTERNATIONAL JOURNAL OF ONCOLOGY
    17. Alonso, V; Escudero, P; Zorrilla, M; Isla, MD; Herrero, A; Mayordomo, JI; Martinez-Trufero, J; Saenz, A; Tres, A; Anton, A
      Phase I trial of weekly irinotecan combined with UFT as second-line treatment for advanced colorectal cancer

      EUROPEAN JOURNAL OF CANCER
    18. Guichard, S; Arnould, S; Hennebelle, I; Bugat, R; Canal, P
      Combination of oxaliplatin and irinotecan on human colon cancer cell lines: activity in vitro and in vivo

      ANTI-CANCER DRUGS
    19. Yamamoto, W; Verweij, J; de Bruijn, P; de Jonge, MJA; Takano, H; Nishiyama, M; Kurihara, M; Sparreboom, A
      Active transepithelial transport of irinotecan (CPT-11) and its metabolites by human intestinal Caco-2 cells

      ANTI-CANCER DRUGS
    20. Kehrer, DFS; Soepenberg, O; Loos, WJ; Verweij, J; Sparreboom, A
      Modulation of camptothecin analogs in the treatment of cancer: a review

      ANTI-CANCER DRUGS
    21. Battistel, OA; Dallabona, G
      Ambiguities versus gauge invariance in the calculation of the radiatively induced Chern-Simons shift in extended QED

      JOURNAL OF PHYSICS G-NUCLEAR AND PARTICLE PHYSICS
    22. Niitsu, N; Iijima, K; Chizuka, A
      Combination therapy with irinotecan (CPT-11), mitoxantrone, and dexamethasone in relapsed or refractory non-Hodgkin's lymphoma: a pilot study

      ANNALS OF HEMATOLOGY
    23. Fallgatter, AJ; Muller, TJ
      Electrophysiological signs of reduced prefrontal response control in schizophrenic patients

      PSYCHIATRY RESEARCH-NEUROIMAGING
    24. Rothenberg, ML; Kuhn, JG; Schaaf, LJ; Rodriguez, GI; Eckhardt, SG; Villalona-Calero, MA; Rinaldi, DA; Hammond, LA; Hodges, S; Sharma, A; Elfring, GL; Petit, RG; Locker, PK; Miller, LL; von Hoff, DD
      Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks

      ANNALS OF ONCOLOGY
    25. Sitenko, YA
      On the induced Chern-Simons term in the effective action in 3+1 dimensions

      NUCLEAR PHYSICS B-PROCEEDINGS SUPPLEMENTS
    26. Oguma, T; Yamada, M; Konno, T; Inukai, K; Nakaoka, M
      High-performance liquid chromatographic analysis of lactone and hydroxy acid of new antitumor drug, DX-8951 (Exatecan), in mouse plasma

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    27. Sakai, C; Iuchi, T; Ishii, A; Kumagai, K; Takagi, T
      Bacillus cereus brain abscesses occurring in a severely neutropenic patient: Successful treatment with antimicrobial agents, granulocyte colony-stimulating factor and surgical drainage

      INTERNAL MEDICINE
    28. Shimizu, M; Tamura, T; Yamada, Y; Akiyama, Y; Saijo, N; Nishio, K
      CPT-11 alters the circadian rhythm of dihydropyrimidine dehydrogenase mRNAin mouse liver

      JAPANESE JOURNAL OF CANCER RESEARCH
    29. Khayat, D; Gil-Delgado, M; Antoine, EC; Nizri, D; Bastian, G
      The role of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer

      ONCOLOGY-NEW YORK
    30. Rich, TA; Kirichenko, AV
      Camptothecin schedule and timing of administration with irradiation

      ONCOLOGY-NEW YORK
    31. O'Reilly, EM; Ilson, DH
      Cisplatin and irinotecan in upper gastrointestinal malignancies

      ONCOLOGY-NEW YORK
    32. Lima, CMSR; Sherman, CA; Brescia, FJ; Brunson, CY; Green, MR
      Irinotecan/gemcitabine combination chemotherapy in pancreatic cancer

      ONCOLOGY-NEW YORK
    33. Adler, CM; Sax, KW; Holland, SK; Schmithorst, V; Rosenberg, L; Strakowski, SM
      Changes in neuronal activation with increasing attention demand in healthyvolunteers: An fMRI study

      SYNAPSE
    34. Socinski, MA; Sandler, AB; Miller, LL; Locker, PK; Hanover, CK; Elfring, GL; Israel, VK; Pirotta, N; Natale, RB
      Phase I trial of the combination of irinotecan, paclitaxel, and carboplatin in patients with advanced non-small-cell lung cancer

      JOURNAL OF CLINICAL ONCOLOGY
    35. Becouarn, Y; Gamelin, E; Coudert, B; Negrier, S; Pierga, JY; Raoul, JL; Provencal, J; Rixe, O; Krisch, C; Germa, C; Bekradda, M; Mignard, D; Mousseau, M
      Randomized multicenter phase II study comparing a combination of fluorouracil and folinic acid and alternating irinotecan and oxaliplatin with oxaliplatin and irinotecan in fluorouracil-pretreated metastatic colorectal cancer patients

      JOURNAL OF CLINICAL ONCOLOGY
    36. Falcone, A; Di Paolo, A; Masi, G; Allegrini, G; Danesi, R; Lencioni, M; Pfanner, E; Comis, S; Del Tacca, M; Conte, P
      Sequence effect of irinotecan and fluorouracil treatment on pharmacokinetics and toxicity in chemotherapy-naive metastatic colorectal cancer patients

      JOURNAL OF CLINICAL ONCOLOGY
    37. Arimori, K; Kuroki, N; Kumamoto, A; Tanoue, N; Nakano, M; Kumazawa, E; Tohgo, A; Kikuchi, M
      Excretion into gastrointestinal tract of irinotecan lactone and carboxylate forms and their pharmacodynamics in rodents

      PHARMACEUTICAL RESEARCH
    38. Hewett, JL; Petriello, FJ; Rizzo, TG
      Signals for noncommutative interactions at linear colliders - art. no. 075012

      PHYSICAL REVIEW D
    39. Kostelecky, VA
      CPT, T, and Lorentz violation in neutral-meson oscillations - art. no. 076001

      PHYSICAL REVIEW D
    40. Kostelecky, VA; Lehnert, R
      Stability, causality, and Lorentz and CPT violation - art. no. 065008

      PHYSICAL REVIEW D
    41. Scarpelli, APB; Sampaio, M; Nemes, MC
      Consistency relations for an implicit n-dimensional regularization scheme - art. no. 046004

      PHYSICAL REVIEW D
    42. Kostelecky, VA; Potting, R
      Analytical construction of a nonperturbative vacuum for the open bosonic string - art. no. 046007

      PHYSICAL REVIEW D
    43. Ellis, J; Mavromatos, NE; Nanopoulos, DV
      How large are dissipative effects in noncritical Liouville string theory? art. no. 024024

      PHYSICAL REVIEW D
    44. Klinkhamer, FR; Mayer, C
      Torsion, topology and CPT anomaly in two-dimensional chiral U(1) gauge theory

      NUCLEAR PHYSICS B
    45. Battistel, OA; Dallabona, G
      Role of ambiguities and gauge invariance in the calculation of the radiatively induced Chern-Simons shift in extended QED

      NUCLEAR PHYSICS B
    46. Adam, C; Klinkhamer, FR
      Causality and CPT violation from an Abelian Chern-Simons-like term

      NUCLEAR PHYSICS B
    47. Csaki, C; Erlich, J; Grojean, C
      Gravitational Lorentz violations and adjustment of the cosmological constant in asymmetrically warped spacetimes

      NUCLEAR PHYSICS B
    48. Bonneau, G
      Regularisation, many recipes, but a unique principle: Ward identities and normalisation conditions. The case of CPT violation in QED

      NUCLEAR PHYSICS B
    49. Wallace, RA; Klestov, AC; Kubler, PA
      Emotional distress induced rhabdomyolysis in an individual with carnitine palmitolytransferase deficiency

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    50. Isgur, N; Kostelecky, VA; Szczepaniak, AP
      Background enhancement of CPT reach at an asymmetric phi factory

      PHYSICS LETTERS B
    51. Adam, C; Klinkhamer, FR
      Causality and radiatively induced CPT violation

      PHYSICS LETTERS B
    52. Colladay, D; Kostelecky, VA
      Cross sections and lorentz violation

      PHYSICS LETTERS B
    53. Andrianov, AA; Taron, J; Tarrach, R
      Neutral kaons in medium: decoherence effects

      PHYSICS LETTERS B
    54. Osinov, VA; Cudmani, R
      Theoretical investigation of the cavity expansion problem based on a hypoplasticity model

      INTERNATIONAL JOURNAL FOR NUMERICAL AND ANALYTICAL METHODS IN GEOMECHANICS
    55. Sloan, JA; Atherton, P; Reid, J; Pilot, HC; Erlichman, C; Schaaf, L
      Limited sampling models for CPT-11, SN-38, and SN-38 glucuronide

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    56. Takeda, K; Negoro, S; Takifuji, N; Nitta, T; Yoshimura, N; Terakawa, K; Fukuoka, M
      Dose escalation study of irinotecan combined with carboplatin for advancednon-small-cell lung cancer

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    57. Sato, A; Kurihara, M; Matsukawa, M; Shimada, K; Yamazaki, T; Nakamachi, M; Koda, T
      Preliminary study of fortnightly irinotecan hydrochloride plus cisplatin therapy in patients with advanced gastric and colorectal cancer

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    58. Guemei, AA; Cottrell, J; Band, R; Hehman, H; Prudhomme, M; Pavlov, MV; Grem, JL; Ismail, AS; Bowen, D; Taylor, RE; Takimoto, CH
      Human plasma carboxylesterase and butyrylcholinesterase enzyme activity: correlations with SN-38 pharmacokinetics during a prolonged infusion of irinotecan

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    59. Kobayashi, K; Ceryak, S; Matsuzaki, Y; Kudoh, S; Bouscarel, B
      Effect of bile acids on the uptake of irinotecan and its active metabolite, SN-38, by intestinal cells

      BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
    60. Mitani, N; Murakami, K; Yamaura, T; Ikeda, T; Saiki, I
      Inhibitory effect of berberine on the mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma

      CANCER LETTERS
    61. Fallgatter, AJ
      Electrophysiology of the prefrontal cortex in healthy controls and schizophrenic patients: a review

      JOURNAL OF NEURAL TRANSMISSION
    62. Grifalchi, F; Padovani, A; Romeo, F; Trinca, C; Moscetti, L; Cortesi, E
      Response of metastatic epidermoid anal cancer to single agent irinotecan: A case report

      TUMORI
    63. Arduini, A; Zibellini, G; Ferrari, L; Magnanimi, L; Dottori, S; Lohninger, A; Carminati, P
      Participation of carnitine palmitoyltransferase in the synthesis of dipalmitoylphosphatidylcholine in rat alveolar type II cells

      MOLECULAR AND CELLULAR BIOCHEMISTRY
    64. Broadway, NM; Pease, RJ; Birdsey, G; Turner, NA; Shayeghi, M; Saggerson, ED
      Microsomal malonyl-CoA-sensitive carnitine acyltransferase

      BIOCHEMICAL SOCIETY TRANSACTIONS
    65. Zammit, VA; Price, NT; Fraser, F; Jackson, VN
      Structure-function relationships of the liver and muscle isoforms of carnitine palmitoyltransferase I

      BIOCHEMICAL SOCIETY TRANSACTIONS
    66. Gil-Delgado, MA; Antoine, EC; Guinet, F; Bassot, V; Grapin, JP; Benhammonda, A; Adam, R; Castaing, D; Bismuth, H; Khayat, D
      Phase I-II study of irinotecan in combination with mitomycin C in patientswith advanced gastrointestinal cancer

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    67. Gil-Delgado, MA; Guinet, F; Castaing, D; Adam, R; Coeffic, D; Durrani, AKS; Bismuth, H; Khayat, D
      Prospective phase II trial of irinotecan, 5-fluorouracil, and leucovorin in combination as salvage therapy for advanced colorectal cancer

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    68. Topcu, Z
      DNA topoisomerases as targets for anticancer drugs

      JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
    69. Lansiaux, A; Bras-Goncalves, RA; Rosty, C; Laurent-Puig, P; Poupon, MF; Bailly, C
      Topoisomerase I-DNA covalent complexes in human colorectal cancer xenografts with different p53 and microsatellite instability status: Relation with their sensitivity to CTP-11

      ANTICANCER RESEARCH
    70. Amelino-Camelia, G
      Planck-length phenomenology

      INTERNATIONAL JOURNAL OF MODERN PHYSICS D
    71. Dass, GV
      Testing reciprocity and CPT-invariance for neutral kaons

      MODERN PHYSICS LETTERS A
    72. Gonzalez-Garrido, AA; Gomez-Velazquez, FR; Fernandez-Harmony, T; de Alba, JLO; Ruiz-Sandoval, JL
      Event-related brain potentials during a continuous performance test (CPT) task in normal children

      ARCHIVES OF MEDICAL RESEARCH
    73. Bertel, F; Mortemousque, B; Sicard, H; Andre, C
      Conjunctival provocation test

      JOURNAL FRANCAIS D OPHTALMOLOGIE
    74. Pakvasa, S
      Testing neutrino properties at long baseline experiments and neutrino factories

      NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT
    75. Tao, Y; Lam, ECM; Tang, YY
      Feature extraction using wavelet and fractal

      PATTERN RECOGNITION LETTERS
    76. Vokes, EE; Gordon, GS; Rudin, CM; Mauer, AM; Watson, S; Krauss, S; Arrieta, R; Golomb, HM; Hoffman, PC
      A phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancer

      INVESTIGATIONAL NEW DRUGS
    77. Pro, B; Lozano, R; Ajani, JA
      Therapeutic response to octreotide in patients with refractory CPT-11 induced diarrhea

      INVESTIGATIONAL NEW DRUGS
    78. Lima, CMSR; Urbanic, JJ; Lal, A; Kneuper-Hall, R; Brunson, CY; Green, MR
      Beyond pancreatic cancer: Irinotecan and gemcitabine in solid tumors and hematologic malignancies

      SEMINARS IN ONCOLOGY
    79. Sai, K; Kaniwa, N; Ozawa, S; Sawada, JI
      A new metabolite of irinotecan in which formation is mediated by human hepatic cytochrome P-450 3A4

      DRUG METABOLISM AND DISPOSITION
    80. Hanioka, N; Ozawa, S; Jinno, H; Ando, M; Saito, Y; Sawada, J
      Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin

      XENOBIOTICA
    81. Carroll, SM; Harvey, JA; Kostelecky, VA; Lane, CD; Okamoto, T
      Noncommutative field theory and Lorentz violation - art. no. 141601

      PHYSICAL REVIEW LETTERS
    82. Abe, K; Abe, K; Adachi, I; Ahn, BS; Aihara, H; Akatsu, M; Alimonti, G; Aoki, K; Asai, K; Asai, M; Asano, Y; Aso, T; Aulchenko, V; Aushev, T; Bakich, AM; Banas, E; Behari, S; Behera, PK; Beiline, D; Bondar, A; Bozek, A; Browder, TE; Casey, BCK; Chang, P; Chao, Y; Cheon, BG; Choi, SK; Choi, Y; Doi, Y; Dragic, J; Eidelman, S; Enari, Y; Enomoto, R; Everton, CW; Fang, F; Fujii, H; Fujita, Y; Fukunaga, C; Fukushima, M; Garmash, A; Gordon, A; Gotow, K; Guler, H; Guo, R; Haba, J; Haji, T; Hamasaki, H; Hanagaki, K; Handa, F; Hara, K; Hara, T; Hastings, NC; Hayashi, K; Hayashii, H; Hazumi, M; Heenan, EM; Higuchi, I; Higuchi, T; Hirai, T; Hirano, H; Hojo, T; Hoshi, Y; Hou, WS; Hsu, SC; Huang, HC; Haung, YC; Ichizawa, S; Igarashi, Y; Iijima, T; Ikeda, H; Ikeda, K; Inami, K; Inoue, Y; Ishikawa, A; Ishino, H; Itoh, R; Iwai, G; Iwasaki, H; Iwasaki, Y; Jackson, DJ; Jalocha, P; Jang, HK; Jones, M; Kagan, R; Kakuno, H; Kaneko, J; Kang, JH; Kang, JS; Kapusta, P; Kasami, K; Katayama, N; Kawai, H; Kawai, M; Kawamura, N; Kawasaki, T; Kichimi, H; Kim, DW; Kim, H; Kim, HJ; Kim, H; Kim, SK; Kinoshita, K; Kobayashi, S; Koike, S; Koishi, S; Konishi, H; Korotushenko, K; Krokovny, P; Kulasiri, R; Kumar, S; Kuniya, T; Kurihara, E; Kuzmin, A; Kwon, YJ; Lee, MH; Lee, SH; Leonidopoulos, C; Li, HB; Lu, RS; Makida, Y; Manabe, A; Marlow, D; Matsubara, T; Matsuda, T; Matsui, S; Matsumoto, S; Matsumoto, T; Miyabayashi, K; Miyake, H; Miyata, H; Moffitt, LC; Mohapatra, A; Moloney, GR; Moorhead, GF; Mori, S; Mori, T; Murakami, A; Nagamine, T; Nagasaka, Y; Nagashima, Y; Nakadaira, T; Nakano, E; Nakao, M; Nakazawa, H; Nam, JW; Narita, S; Natkaniec, Z; Neichi, K; Nishida, S; Nitoh, O; Noguchi, S; Nozaki, T; Ogawa, S; Ohshima, T; Ohshima, Y; Okabe, T; Okazaki, T; Okuno, S; Olsen, SL; Ozaki, H; Pakhlov, P; Palka, H; Park, CS; Park, CW; Park, H; Peak, LS; Peters, M; Piilonen, LE; Prebys, E; Raaf, J; Rodriguez, JL; Root, N; Rozanska, M; Rybicki, K; Ryuko, J; Sagawa, H; Sakai, Y; Sakamoto, H; Sakaue, H; Satapathy, M; Sato, N; Satpathy, A; Schrenk, S; Semenov, S; Sevior, ME; Shibuya, H; Shwartz, B; Sidorov, A; Sidorov, V; Stanic, S; Sugi, A; Sugiyama, A; Sumisawa, K; Sumiyoshi, T; Suzuki, J; Suzuki, K; Suzuki, S; Suzuki, SY; Swain, SK; Tajima, H; Takahashi, T; Takasaki, F; Takita, M; Tamai, K; Tamura, N; Tanaka, J; Tanaka, M; Tanaka, Y; Taylor, GN; Teramoto, Y; Tomoto, M; Tomura, T; Tovey, SN; Trabelsi, K; Tsuboyama, T; Tsujita, Y; Tsukamoto, T; Tsukamoto, T; Uehara, S; Ueno, K; Ujiie, N; Unno, Y; Uno, S; Ushiroda, Y; Usov, Y; Vahsen, SE; Varner, G; Varvell, KE; Wang, CC; Wang, CH; Wang, MZ; Wang, TJ; Watanabe, Y; Won, E; Yabsley, BD; Yamada, Y; Yamaga, M; Yamaguchi, A; Yamaguchi, H; Yamaoka, H; Yamaoka, Y; Yamashita, Y; Yamauchi, M; Yanaka, S; Yokoyama, M; Yoshida, K; Yusa, Y; Yuta, H; Zhang, CC; Zhao, HW; Zheng, Y; Zhilich, V; Zontar, D
      Measurement of B-d(0)-(B)over-bar(d)(0) mixing rate from the time evolution of dilepton events at the Upsilon(4S)

      PHYSICAL REVIEW LETTERS
    83. Dobrez, D; Lo Sasso, A; Holl, J; Shalowitz, M; Leon, S; Budetti, P
      Estimating the cost of developmental and behavioral screening of preschoolchildren in general pediatric practice

      PEDIATRICS
    84. Kakolyris, S; Souglakos, J; Kouroussis, C; Androulakis, N; Mavroudis, D; Kalbakis, K; Kotsakis, A; Vardakis, N; Koukourakis, M; Romanos, J; Georgoulias, V
      A dose-finding study of irinotecan (CPT-11) plus a four-day continuous 5-fluorouracil infusion in advanced colorectal cancer

      ONCOLOGY
    85. Comella, P; Biglietto, M; Casaretti, R; De Luica, L; Avallone, A; Maiorino, L; Di Lullo, L; De Cataldis, G; Rivellini, F; Comella, G
      Irinotecan and mitomycin C in 5-fluorouracil-refractory colorectal cancer patients - A phase I/II study of the Southern Italy Cooperative Oncology Group

      ONCOLOGY
    86. Fallgatter, AJ; Herrmann, MJ
      Electrophysiological assessment of impulsive behavior in healthy subjects

      NEUROPSYCHOLOGIA
    87. Amelino-Camelia, G
      A phenomenological description of space-time noise in quantum gravity

      NATURE
    88. Wadkins, RM; Morton, CL; Weeks, JK; Oliver, L; Wierdl, M; Danks, MK; Potter, PM
      Structural constraints affect the metabolism of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) by carboxylesterases

      MOLECULAR PHARMACOLOGY
    89. Nieuwenstein, MR; Aleman, A; de Haan, EHF
      Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies

      JOURNAL OF PSYCHIATRIC RESEARCH
    90. Farabos, C; Haaz, MC; Gires, P; Robert, J
      Hepatic extraction, metabolism, and biliary excretion of irinotecan in theisolated perfused rat liver

      JOURNAL OF PHARMACEUTICAL SCIENCES
    91. Shioiri, C; Takahata, N
      Skew of mononucleotide frequencies, relative abundance of dinucleotides, and DNA strand asymmetry

      JOURNAL OF MOLECULAR EVOLUTION
    92. Chraibi, A; Schnizler, M; Clauss, W; Horisberger, JD
      Effects of 8-cpt-cAMP on the epithelial sodium channel expressed in Xenopus oocytes

      JOURNAL OF MEMBRANE BIOLOGY
    93. Russell, N
      Superalgebras for the Penning trap

      JOURNAL OF MATHEMATICAL PHYSICS
    94. Fraser, F; Padovese, R; Zammit, VA
      Distinct kinetics of carnitine palmitoyltransferase I in contact sites andouter membranes of rat liver mitochondria

      JOURNAL OF BIOLOGICAL CHEMISTRY
    95. Moore, ML; Wang, GL; Belaguli, NS; Schwartz, RJ; McMillin, JB
      GATA-4 and serum response factor regulate transcription of the muscle-specific carnitine palmitoyltransferase I beta in rat heart

      JOURNAL OF BIOLOGICAL CHEMISTRY
    96. Takeda, Y; Kobayashi, K; Akiyama, Y; Soma, T; Handa, S; Kudoh, S; Kudo, K
      Prevention of irinotecan (CPT-11)-induced diarrhea by oral alkalization combined with control of defecation in cancer patients

      INTERNATIONAL JOURNAL OF CANCER
    97. Iyengar, RV; Pawlik, CA; Krull, EJ; Phelps, DA; Burger, RA; Harris, LC; Potter, PM; Danks, MK
      Use of a modified ornithine decarboxylase promoter to achieve efficient c-MYC- or N-MYC-regulated protein expression

      CANCER RESEARCH
    98. Boushey, RP; Yusta, B; Drucker, DJ
      Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor

      CANCER RESEARCH
    99. Wierdl, M; Morton, CL; Weeks, JK; Danks, MK; Harris, LC; Potter, PM
      Sensitization of human tumor cells to CPT-11 via adenoviral-mediated delivery of a rabbit liver carboxylesterase

      CANCER RESEARCH
    100. Meck, MM; Wierdl, M; Wagner, LM; Burger, RA; Guichard, SM; Krull, EJ; Harris, LC; Potter, PM; Danks, MK
      A virus-directed enzyme prodrug therapy approach to purging neuroblastoma cells from hematopoietic cells using adenovirus encoding rabbit carboxylesterase and CPT-11

      CANCER RESEARCH


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/05/20 alle ore 19:53:38